MRK vs DHR
By Alex · Tickerpine
Merck & Company, Inc. vs Danaher Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | DHR |
|---|---|---|
| Price | $132.92 | $205.79 |
| Market cap | $327.94B | $144.67B |
| P/E ratio | 106.3 | 37.0 |
| ROE | 6.96% | 7.61% |
| Profit margin | 4.77% | 15.95% |
| Revenue growth | 5.10% | 5.50% |
| Dividend yield | 2.56% | 0.77% |
| Beta | 0.21 | 0.80 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs DHR in plain English
- MRK is the bigger company — about 2.3× the market cap of DHR.
- DHR is cheaper on earnings (P/E 37.0 vs 106.3).
- DHR earns a higher return on equity (8% vs 7%).
- DHR is growing revenue faster (6% vs 5%).
- MRK has the higher dividend yield (2.56% vs 0.77%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
DHR return calculator
See what $1,000 in Danaher Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.